Daily Effort – Open Lifespan

Daily Effort: The task of philosophy is thought experimenting with relevant possible worlds

Almost all philosophers are giving out hints about their views on what philosophy is or frequently express their metaphilosophy explicitly. Uniquely amongst academic disciplines, philosophy has the tools to conceptualise itself and its methods. I’m not a particularly metaphilosophical philosopher but it seems that for a more complete analysis of Open Lifespan philosophy it’s better to develop the outlines of the metaphilosophy behind to stay on the exoteric side.

Here’s a quick metaphilosophy in a nutshell Continue reading “Daily Effort: The task of philosophy is thought experimenting with relevant possible worlds”

Daily effort: Open Lifespan does not rely on strong anthropocentrism

Anthropocentrism is also known by other names as humanocentrism, human-centeredness or human exceptionalism. It has something to do with attributing a special significance to humans in the universe.

According to the Environmental Ethics entry of Stanford Encyclopedia of Philosophy strong anthropocentrism only assigns intrinsic value to human beings alone. So intrinsic value, whatever it would be, is captured in absolute terms and applied only to humans.

In weak anthropocentrism value assignment gets relative and quantitative by human beings representing greater amount of intrinsic value than any non-human things.

Ecological thinkers and environmental ethicists have a rather easy job finding traces of anthropocentrism in the works of canonical thinkers of Western philosophy.

Object-oriented ontology also attacks and rejects anthropocentrism and moves away from epistemological approaches.

When working out bits and pieces of Open Lifespan philosophy Continue reading

Is life in a box is better than no life at all? Help and hope, so.

Last time I’ve introduced the principle of life’s default positivity, and the first formula provided was the one used by Thomas Nagel in his Death essay:

It is good simply to be alive.

Another way to phrase this is comparatively

It’s better to be alive than dead.

Let me introduce now a potential counterargument, extracted from the words of one of my favourite fictional characters, Rosencrantz, played by Garry Oldman in Stoppard’s Rosencrantz and Guildenstern are dead. Mind you, this is Stoppard’s but not Shakespeare’s Rosencrantz, speaking. How about watching it first:

Here’s the corresponding section from the script: Continue reading “Is life in a box is better than no life at all? Help and hope, so.”

Daily Effort: Thomas Nagel and the principle of life’s default positivity, first take

The thesis or principle I’d like to introduce today is a (possibly) central thesis behind Open Lifespan philosophy and I’ll keep coming back to it throughout this blog and book in the making. I’m going to extract it first from Thomas Nagel’s masterful and dense essay, Death, originally published in Noûs, in 1970 but am actually going to use the edited version published in Mortal Questions, in 1979.

Then I simply try to provide different formulations. So no arguments today, just a start to understand this principle by stating it and have a glimpses at the heavy philosophical concepts behind it.

Nagel’s main problem in the essay is to investigate why and how and when death can be a misfortune (evil, bad) to the persons who died. And it has to do something with bringing ‘to an end all the goods that life contains’.

And in this context the principle is first stated as an ‘allegiation’ that

It is good simply to be alive, even if one is undergoing terrible experiences.

So first formula

1. It is good simply to be alive.

Let’s continue here cause this leads to another formulation of the principle:

Continue reading “Daily Effort: Thomas Nagel and the principle of life’s default positivity, first take”

Daily Effort: Can we build a better self without building a better world?

Our daily today is posing a heavy philosophical question: can we build a better self without building a better world? For understanding the level of this question one needs to take a moral/ethical concept of the self granted. But we don’t need to dig into the depth of the malleability of personal identity, but mostly focus on our narrative, social construct of our selves that is a prime bearer of moral values and changes and agent of moral decisions. Continue reading “Daily Effort: Can we build a better self without building a better world?”

Daily Effort: Life extension belongs to the ICU, Open Lifespan belongs to everybody

In the opening post of this blog I started by saying ‘Life extension’ as a term referring to healthy longevity technologies and attempts just does not cut it anymore and I cited luxury as one reason. There’s another important reason, coming from the already existing medical use of this term to ditch this concept to be used for our Open Lifespan purposes. The terms ‘life extension’, ‘extending life’ are used in the medical context to provide extra days, weeks, months to late stage, terminally diseased people, think of a final stage lung cancer patient. Continue reading “Daily Effort: Life extension belongs to the ICU, Open Lifespan belongs to everybody”

Daily Effort: Pharmacodiligence plus, potential, positive lifespan side effects on drug labels?

Attempting a new post series called Daily Effort: a dense expression of an Open Lifespan/Open Healthspan related idea (question, argument, proposal …) in a couple of sentences. Without context or tight, detailed argumentation. Consider these as drafts, some of them will be elaborated upon, some of them will be revoked if don’t stand up to scrutiny. In any case, these are my drafts here am working on, reaching a stage where it might be interesting for others too. Let’s go.

Today’s idea is simple and I phrase it as a question (and a bundle of follow-up questions), rather than a proposal as originally intended: if a drug has reported and potential lifespan and/or healthspan lengthening benefits, should this information be printed on the label too amongst potential side effects? Think of metformin here as a prime example where observational evidence suggests longer survival time for metformin user diabetics compared to non-diabetic, non-users. Continue reading “Daily Effort: Pharmacodiligence plus, potential, positive lifespan side effects on drug labels?”